Preparation and characterization of flurbiprofen-loaded poly(3-hydroxybutyrate-co-3-hydroxyvalerate) microspheres

References

• Baran ET, Ozer N, Hasirci V. Poly(hydroxybutyrate-co-hydroxyvalerate) nanocapsules as enzyme carriers for cancer therapy: an in vitro study. J Microencapsulation 2002; 19: 363–376
   PubMed Web of Science ®Google Scholar
• Bolourtchian N, Karimi K, Aboofazeli R. Preparation and characterization of ibuprofen microspheres. J Microencapsulation 2005; 22: 529–538
   PubMed Web of Science ®Google Scholar
• Chen J, Davis SS. The release of diazepam from poly(hydroxybutyrate-co-hydroxyvalerate) microspheres. J Microencapsulation 2002; 19: 191–201
   PubMed Web of Science ®Google Scholar
• Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998; 104: 413–421
   PubMed Web of Science ®Google Scholar
• Dubernet C. Thermoanalysis of microspheres. Thermochim Acta 1995; 248: 259–269
   Web of Science ®Google Scholar
• Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm 2004; 282: 1–18
   PubMed Web of Science ®Google Scholar
• Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: Reviewing the state of the art of microsphere preparation process technology. J Control Rel 2005; 102: 313–332
   PubMed Web of Science ®Google Scholar
• Fu X, Ping Q, Gao Y. Effects of formulation factors on encapsulation efficiency and release behaviour in vitro of huperzine A-PLGA microspheres. J Microencapsulation 2005; 22: 705–714
   PubMed Web of Science ®Google Scholar
• Gunaratne LM, Shanks RA. Multiple melting behaviour of poly(3-hydroxybutyrate-co-hydroxyvalerate) using step-scan DSC. Eur Polym J 2005; 41: 2980–2988
   Web of Science ®Google Scholar
• Hyon SH. Biodegradable poly(lactic acid) microspheres for drug delivery system. Yonsei Med J 2000; 41: 720–734
   PubMed Web of Science ®Google Scholar
• Khang G, Kim SW, Cho JC, Rhee JM, Yoon SC, Lee HB. Preparation and characterization of poly(hydroxybutyrate-co-hydroxyvalerate) microspheres for the sustained release of 5-fluorouracil. Bio-Med Mater Eng 2001; 11: 89–105
   PubMed Web of Science ®Google Scholar
• Lai MK, Tsiang RCC. Encapsulating acetaminophen into poly(L-lactide) microcapsules by solvent evaporation technique in O/W emulsion. J Microencapsulation 2004; 21: 307–316
   PubMed Web of Science ®Google Scholar
• Li P, Zhao L. Solubilization of flurbiprofen in pH-surfactant solutions. J Pharm Sci 2003; 92: 951–956
   PubMed Web of Science ®Google Scholar
• Lu Y, Zhang G, Sun D, Zhong Y. Preparation and evaluation of biodegradable gelatin micro-spheres for intra-articular administration. J Microencapsulation 2007; 4: 515–524
   Google Scholar
• Martin MA, Miguens FC, Rieumont J, Sanchez R. Tailoring of the external and internal morphology of poly-3-hydroxybutyrate microparticles. Colloids Surf B: Biointerf 2000; 17: 111–116
   Web of Science ®Google Scholar
• Montgomery DC. Design and analysis of experiments. 5th ed. Wiley, New York 2001
   Google Scholar
• O’Donnell P, McGinity J. Preparation of microspheres by the solvent evaporation technique. Adv Drug Del Rev 1997; 28: 25–42
   PubMed Web of Science ®Google Scholar
• Park KM, Kim CK. Preparation and evaluation of flurbiprofen-loaded microemulsion for parenteral delivery. Int J Pharm 1999; 181: 173–179
   PubMed Web of Science ®Google Scholar
• Park SH, Choi HK. The effects of surfactants on the dissolution profiles of poorly water-soluble acidic drugs. Int J Pharm 2006; 321: 35–41
   PubMed Web of Science ®Google Scholar
• Pignatello R, Bucolo C, Spedalieri G, Maltese A, Puglisi G. Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application. Biomaterials 2002; 23: 3247–3255
   PubMed Web of Science ®Google Scholar
• Pouton CW, Akhtar S. Biosynthetic polyhydroxyalkanoates and their potential in drug delivery. Adv Drug Deliv Rev 1996; 18: 133–162
   Web of Science ®Google Scholar
• Qu XH, Wu Q, Zhang KY, Chen GQ. In vivo studies of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) based polymers: Biodegradation and tissue reactions. Biomaterials 2006; 27: 3540–3548
   PubMed Web of Science ®Google Scholar
• Samati Y, Yüksel N, Tarimci N. Preparation and characterization of poly(D,L-lactic-co-glycolic acid) microspheres containing furbiprofen sodium. Drug Deliv 2006; 13: 105–111
   PubMed Web of Science ®Google Scholar
• Vega E, Egea MA, Valls O, Espina M, García ML. Flurbiprofen loaded biodegradable nanoparticles for ophthalmic administration. J Pharm Sci 2006; 95: 2393–2405
   PubMed Web of Science ®Google Scholar
• Williams SF, Martin DP, Horowitz DM, Peoples OP. PHA applications: Addressing the price performance issue I. Tissue engineering. Int J Biol Macromol 1999; 25: 111–121
   PubMed Web of Science ®Google Scholar
• Yiyun C, Jiepin Y. Solubilization of non-steroidal anti-inflammatory drugs in the presence of tween series surfactants. Phys Chem Liq 2005; 44: 249–256
   Google Scholar
• Zaghloul AA, Vaithiyalingam SR, Faltinek J, Reddy IK, Khan MA. Response surface methodology to obtain naproxen controlled release tablets from its microspheres with Eudragit L100-55. J Microencapsulation 2001; 18: 651–662
   PubMed Web of Science ®Google Scholar